1: Hirai H, Ogawa M, Suzuki N, Yamamoto M, Breier G, Mazda O, Imanishi J, Nishikawa SI. Related Articles, Links
Hemogenic and non-hemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis.
Blood. 2002 Sep 19 [epub ahead of print]
PMID: 12393724 [PubMed - as supplied by publisher]
2: Yu WM, Hawley TS, Hawley RG, Qu CK. Related Articles, Links
Immortalization of yolk sac-derived precursor cells.
Blood. 2002 Nov 15;100(10):3828-31.
PMID: 12393673 [PubMed - in process]
3: Huang X, Wong MK, Yi H, Watkins S, Laird AD, Wolf SF, Gorelik E. Related Articles, Links
Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Cancer Res. 2002 Oct 15;62(20):5727-35.
PMID: 12384531 [PubMed - indexed for MEDLINE]
4: Nakopoulou L, Stefanaki K, Panayotopoulou E, Giannopoulou I, Athanassiadou P, Gakiopoulou-Givalou H, Louvrou A. Related Articles, Links
Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.
Hum Pathol. 2002 Sep;33(9):863-70.
PMID: 12378509 [PubMed - indexed for MEDLINE]
5: Lin B, Podar K, Gupta D, Tai YT, Li S, Weller E, Hideshima T, Lentzsch S, Davies F, Li C, Weisberg E, Schlossman RL, Richardson PG, Griffin JD, Wood J, Munshi NC, Anderson KC. Related Articles, Links
The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
Cancer Res. 2002 Sep 1;62(17):5019-26.
PMID: 12208756 [PubMed - indexed for MEDLINE]
Time used: 31 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005